Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Net Margin: 2019-2025

Historic Net Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to -8.58%.

  • Eton Pharmaceuticals' Net Margin fell 1465.00% to -8.58% in Q3 2025 from the same period last year, while for Sep 2025 it was -12.19%, marking a year-over-year decrease of 260.00%. This contributed to the annual value of -9.80% for FY2024, which is 684.00% down from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Net Margin is -8.58%, which was up 37.17% from -13.66% recorded in Q2 2025.
  • Eton Pharmaceuticals' Net Margin's 5-year high stood at 43.00% during Q1 2021, with a 5-year trough of -786.32% in Q3 2021.
  • In the last 3 years, Eton Pharmaceuticals' Net Margin had a median value of -8.58% in 2025 and averaged -16.45%.
  • Data for Eton Pharmaceuticals' Net Margin shows a peak YoY increase of 2,358,427bps (in 2021) and a maximum YoY decrease of 25,621,628bps (in 2021) over the last 5 years.
  • Over the past 5 years, Eton Pharmaceuticals' Net Margin (Quarterly) stood at 17.05% in 2021, then slumped by 632bps to 10.73% in 2022, then crashed by 1,830bps to -7.57% in 2023, then soared by 244bps to -5.13% in 2024, then plummeted by 1,465bps to -8.58% in 2025.
  • Its Net Margin stands at -8.58% for Q3 2025, versus -13.66% for Q2 2025 and -88.02% for Q1 2025.